Activation of Adenoviral Gene Expression by Protein IX Is Not Required for Efficient Virus Replication

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Virology

• Publication date

  2004-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.78.10.5032-5037.2004PMID 15113884PMCID PMC400331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors

  2004influential reference
• Adenovirus protein IX sequesters host‐cell promyelocytic leukaemia protein and contributes to efficient viral proliferation

  2003cited by this paper
• Cancer therapy utilizing an adenoviral vector expressing only E1A

  2002cited by this paper
• Functional Analysis of Adenovirus Protein IX Identifies Domains Involved in Capsid Stability, Transcriptional Activity, and Nuclear Reorganization

  2001influential reference
• Effects of Stuffer DNA on Transgene Expression from Helper-Dependent Adenovirus Vectors

  1999cited by this paper
• The product of the adenovirus intermediate gene IX is a transcriptional activator

  1997influential reference
• Viral transactivating proteins.

  1997cited by this paper
• Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line.

  1997cited by this paper
• A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging

  1997cited by this paper
• Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli

  1996cited by this paper
• Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre

  1996cited by this paper
• A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal.

  1996cited by this paper
• Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes.

  1987influential reference
• Adenovirus type 5 virions can be assembled in vivo in the absence of detectable polypeptide IX

  1981cited by this paper
• Characterization of adenovirus protein IX.

  1979cited by this paper
• Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

  1977cited by this paper

• Understanding the performance of HIV-1 viral vector vaccines: adenovirus and poxvirus case studies

  2026cites this paper
• Identification of human adenovirus replication inhibitors from a library of small molecules targeting cellular epigenetic regulators

  2020cites this paper
• Fusion of Large Polypeptides to Human Adenovirus Type 5 Capsid Protein IX Can Compromise Virion Stability and DNA Packaging Capacity

  2020cites this paper
• Exosomes: A Novel Biomarker and Approach to Gene Therapy for Spinal Muscular Atrophy

  2019cites this paper
• Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX.

  2018cites this paper
• Bovine adenovirus type 3 virions cannot be rescued in vivo after full-length viral genome transfection in the absence of detectable polypeptide IX

  2017cites this paper
• Functional implications of the nucleoporin Nup358/RanBP2 and transport receptors in adenoviral genome delivery

  2017cites this paper
• Human adenovirus type 5 vectors deleted of early region 1 (E1) undergo limited expression of early replicative E2 proteins and DNA replication in non-permissive cells

  2017cites this paper
• A Novel Vaccine Approach for Chagas Disease Using Rare Adenovirus Serotype 48 Vectors

  2016cites this paper
• Epitope Capsid-Incorporation: A New Effective Approach for Vaccine Development for Chagas Disease

  2016cites this paper
• Adenovirus-Mediated Expression of the p14 Fusion-Associated Small Transmembrane Protein Promotes Cancer Cell Fusion and Apoptosis In Vitro but Does Not Provide Therapeutic Efficacy in a Xenograft Mouse Model of Cancer

  2016cites this paper
• Improving Adenovirus Efficacy with p14 Fusion Associated Small Transmembrane Protein Expression for Cancer Treatment

  2015cites this paper
• The Adenovirus Genome Contributes to the Structural Stability of the Virion

  2014cites this paper
• Adenoviral protein V promotes a process of viral assembly through nucleophosmin 1.

  2012cites this paper
• Improvement of oncolytic adenovirus vectors through genetic capsid modifications

  2012cites this paper
• Constitutive Augmentation of Heat Shock Response in a Producer Cell for Viral Vaccines

  2012cites this paper
• Use of Cre/loxP recombination to swap cell binding motifs on the adenoviral capsid protein IX.

  2011cites this paper
• Kinesin-1-mediated capsid disassembly and disruption of the nuclear pore complex promote virus infection.

  2011cites this paper
• Retargeting of Adenovirus Vectors through Genetic Fusion of a Single-Chain or Single-Domain Antibody to Capsid Protein IX

  2010cites this paper
• Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors

  2010cites this paper
• Oncolytic adenovirus vectors for nitroreductase suicide gene therapy of prostate cancer

  2010cites this paper
• Evaluation of adenovirus capsid labeling versus transgene expression

  2010cites this paper
• FACULTY OF GRADUATE AND POSDOCTORAL STUDIES

  2010cites this paper
• Adenoviral Producer Cells

  2010cites this paper
• Modification of adenovirus capsid proteins for gene therapy applications

  2009cites this paper
• An avian cell line designed for production of highly attenuated viruses.

  2009cites this paper
• Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IX.

  2008cites this paper
• DNA Genome Size Affects the Stability of the Adenovirus Virion

  2008cites this paper
• Expression of heterologous genes in oncolytic adenoviruses using picornaviral 2A sequences that trigger ribosome skipping.

  2008cites this paper
• Interferon regulatory factor-3 activation in adenovirus infection

  2007cites this paper
• Thermostability/infectivity defect caused by deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in the core protein X precursor.

  2007cites this paper
• Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells.

  2006cites this paper
• Comparative genomic analysis of two strains of human adenovirus type 3 isolated from children with acute respiratory infection in southern China.

  2006cites this paper
• Characterization of the IIIa protein of porcine adenovirus type 3

  2006cites this paper
• Functional and applied studies on the adenovirus minor capsid protein IX

  2006cites this paper
• Molecular and Functional Characterization of the IIIa Protein of Porcine Adenovirus Type 3

  2006cites this paper
• Adenovirus protein IX: a new look at an old protein.

  2005cites this paper
• Genomic and Bioinformatics Analysis of HAdV-4, a Human Adenovirus Causing Acute Respiratory Disease: Implications for Gene Therapy and Vaccine Vector Development

  2005cites this paper
• Adenoviral-mediated transduction of human pancreatic islets: importance of adenoviral genome for cell viability and association with a deficient antiviral response.

  2005cites this paper
• Genomic and bioinformatics analysis of HAdV-7, a human adenovirus of species B1 that causes acute respiratory disease: implications for vector development in human gene therapy.

  2005cites this paper
• The adenovirus capsid: major progress in minor proteins.

  2005cites this paper
• The Coiled-Coil Domain of the Adenovirus Type 5 Protein IX Is Dispensable for Capsid Incorporation and Thermostability

  2005cites this paper
• Fluorescently tagged canine adenovirus via modification with protein IX-enhanced green fluorescent protein.

  2005cites this paper
• Adenoviruses as vaccine vectors

  2004cites this paper
• Use of adenovirus protein IX (pIX) to display large polypeptides on the virion--generation of fluorescent virus through the incorporation of pIX-GFP.

  2004cites this paper